Impact of psychopharmacotherapy on systemic inflammatory response markers in psychosomatic patients: A retrospective study
Open Access
- 6 July 2026
- journal article
- Published by SCEEMP in Safety and Risk of Pharmacotherapy
- Vol. 14 (2) , 155-167
Abstract
INTRODUCTION. The safety of pharmacotherapy in patients with mental disorders is critical for accurate assessment of systemic inflammatory processes. Psychopharmacotherapy may modulate the immune response, potentially masking systemic inflammatory response (SIR) signs in patients with psychosomatic profile. This phenomenon complicates the differential diagnostic process and the selection of an appropriate treatment strategy. AIM. To evaluate the effect of pre-admission psychotropic medication use on key markers of systemic inflammatory response (body temperature, leukocytosis, and C-reactive protein (CRP) levels) to enhance the safety of psychotropic pharmacotherapy and optimize therapeutic strategies in hospitalized patients with mental disorders. MATERIALS AND METHODS. This single-center retrospective study analyzed data from 850 patients hospitalized between January 2024 and March 2025 with suspected infectious complications or decompensation of somatic pathology. Five classes of psychopharmacotherapeutic agents were evaluated: antipsychotics ( n= 270), antidepressants ( n= 56), antiepileptics ( n= 94), anxiolytics ( n= 15), and antiparkinsonian agents ( n= 63). Associations with febrile response (38 °C), leukocytosis, and elevated CRP levels were assessed using the Pearson χ² test, Fisher's exact test, and the linear-by-linear association test. RESULTS. No single drug class affected all three markers of SIR simultaneously. Antidepressant use was associated with a significant linear trend toward reduced fever severity ( p= 0.024). Antiepileptic use was associated with a lower incidence of leukocytosis ( p= 0.039). Polytherapy (use of ≥3 medications) was significantly associated with a decrease in leukocyte counts ( p= 0.008) and an increase in CRP levels ( p= 0.006). Among individual agents, chlorprothixene and chlorpromazine were associated with higher, while risperidone was associated with lower, SIR parameter values. CRP levels during inflammation remained consistently elevated and were not influenced by psychotropic medication use. CONCLUSIONS. Routine psychopharmacotherapy is not a universal confounding factor that distorts the picture of systemic inflammation. The effects are selective and most pronounced in the context of polytherapy. CRP, as the most stable marker, can serve as an objective indicator of inflammation, and data on the effects of individual antipsychotics on SIR markers can be used to optimize therapeutic strategies in patients with comorbid mental and somatic disorders.Keywords
This publication has 17 references indexed in Scilit:
- Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulationTranslational Psychiatry, 2025
- The role of mtDAMPs in the trauma-induced systemic inflammatory response syndromeFrontiers in Immunology, 2023
- Models of pathogenesis of psychosomatic disorders and the concept of psychosomatic scenarioMedical Herald of the South of Russia, 2023
- The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022
- Inflammatory modulation of fluoxetine use in patients with depression: A systematic review and meta-analysisCytokine, 2020
- Impact of antipsychotic medication on IL‐6/STAT3 signaling axis in peripheral blood mononuclear cells of drug‐naive schizophrenia patientsPsychiatry and Clinical Neurosciences, 2019
- Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cellsJournal of Psychiatric Research, 2018
- Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-AnalysisMolecular Neurobiology, 2017
- Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitroJournal of Psychiatric Research, 2013
- Sodium valproate inhibits production of TNF-α and IL-6 and activation of NF-κBBrain Research, 2000